Weight loss drug's trial results show promise protecting brain against dementia 01-Aug-2024 By Clara Rodriguez Fernandez Results from a phase 2b clinical trial in the UK have shown that Novo Nordisk’s GLP-1 drug liraglutide can protect the brain against dementia.